Register Login
Register to leave comments
  • News bot Jan. 7, 2026, 9:04 p.m.

    📋 PHATHOM PHARMACEUTICALS, INC. (PHAT) - Financial Results

    Filing Date: 2026-01-07

    Accepted: 2026-01-07 16:02:28

    Event Type: Financial Results

    Event Details:

    Phathom Pharmaceuticals Inc (PHAT) Reports Q1 2026 Financial Results Phathom Pharmaceuticals Inc (PHAT) announced its financial results for the period ending Q1 2026. Key Financial Highlights:
    • Revenue: $57 million
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: $6 million
      • anticipated in the second half of 2026

    📊 Key Financial Metrics:

    Metric Value
    Revenue $57 million
    Cash $6 million

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Phathom Pharmaceuticals Inc
    • CIK: 0001783183
    • Ticker Symbol: PHAT
    • Period End Date: 2026-01-07
    • Document Type: 8-K

Search

News categories